Collegium Pharmaceutical Inc reports results for the quarter ended in June - Earnings Summary

Collegium Pharmaceutical

03/08/2023 22:38

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of 34 cents​​ per share for the quarter ended
in June. The mean expectation of six analysts for the quarter
was for earnings of 29 cents per share.
    * Revenue rose 9.7% to $135.55 million from a year ago;
analysts
expected $138.40 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 30.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Collegium Pharmaceutical Inc shares had risen by 2.4% this
quarter and lost 5.2% so far this year.
    * The company reported quarterly net income of $14.68
million.
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $34.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:38 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.29           0.34           Beat
 Mar. 31 2023      0.31           -0.51          Missed
 Dec. 31 2022      -0.14          -0.21          Missed
 Sep. 30 2022      -0.13          0.01           Beat